NetworkNewsBreaks Archive - Page 565 of 1742

MondayOct 11, 2021 9:55 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Berubicin’s Impressive Potential in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. According to the update, the audio press release covers CNS Pharmaceuticals’ recent announcement of dosing of the first patients in its Berubicin clinical development program for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types…

MondayOct 11, 2021 9:35 am

NetworkNewsBreaks – Freedom Holding Corp. (NASDAQ: FRHC) Featured in Research Note from Sidoti

Earnings Preview Freedom Holding (NASDAQ: FRHC) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Expect Momentum Continued In 2Q:F22 On Improving Trading Volumes And Economic Outlooks In Key Markets; Highlight Recent M&A, Strong Balance Sheet; Maintain $76 Price Target” Click here to access the full report About Freedom Holding Corp. Freedom Holding Corp., a Nevada corporation, is a financial services holding company conducting retail financial securities brokerage, investment research, investment counseling, securities trading, investment banking and underwriting services and consumer banking through its subsidiaries under the name of Freedom Finance in Eurasia.…

FridayOct 08, 2021 1:18 pm

NetworkNewsBreaks – Why DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Is ‘One to Watch’

DigiMax Global (CSE: DIGI) (OTC: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals. The company’s core solutions include CryptoHawk AI — A deep learning AI solution (“SaaS”) that monitors and analyzes live select cryptocurrencies and financial markets; Cryptocurrency Hedge Fund — A long/short cryptocurrency hedge fund for high net worth, institutional and family office clients; Projected Personality Interpreter (“PPI”) — A solution utilizing AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services; and Navee Predict — An…

FridayOct 08, 2021 12:42 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Committed to Becoming True ‘Farm-to-Door’ Cannabis Company

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, recently updated its current and prospective shareholders to cover key milestones in the company’s strategic plan. The update included details on its growing Nug Avenue operations and additional strides toward verticalizing its model through the acquisition of California cannabis licenses and potentially establishing commercial operations in the cannabis delivery market outside of the state of California. Sugarmade CEO Jimmy Chan described as “tangible” the strides the company continues to make toward a vertically integrated model. “Our long-term strategic vision is to establish the capacity to control all aspects of…

FridayOct 08, 2021 12:14 pm

NetworkNewsBreaks – Simply Sonoma Primed to Benefit from Projected Billion-Dollar Growth of CBD Space

Simply Sonoma, a CBD company focused on building a reputation as a leader in plant-based medicinal health and beauty products, is poised to benefit from the projected billion-dollar growth of the CBD space. This is according to a recent article discussing analysis by Yahoo.finance in a publication titled “CBD Market to Grow to $16 Billion by 2026 — Should You Invest?” The article, which contains excerpts from the publication, reports that increasing awareness of CBD’s therapeutic benefits has influenced buyers to purchase cannabidiol (“CBD”) products, in turn influencing commercial retailers, including those in health and wellness sectors, to now focus…

FridayOct 08, 2021 11:53 am

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Poised as Ideal Partner in Post-Pandemic Insurance Space in China

FingerMotion (OTCQX: FNGR) is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. Following revelations that the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams, Deloitte China proposed that insurers apply big data to facilitate product differentiation and build digital operational capabilities to ensure longevity post-pandemic. In this regard, FingerMotion appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. Through its big data insights division (“Sapientus”), which provides behavioral analytics sourced from publicly available data, FNGR is…

FridayOct 08, 2021 11:37 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Poised to Become Global Leader in Manufacture of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM) recently announced it had signed a definitive agreement to acquire 100% of BayMedica Inc., a U.S.-based private company specializing in the manufacture and commercialization of rare cannabinoids. InMed CEO Eric A. Adams described the acquisition as a transformative transaction for the company as it would give InMed a breadth of synthetic cannabinoid manufacturing capabilities. “BayMedica brings unparalleled cannabinoid manufacturing expertise in both chemical synthesis and biosynthesis together with industry veterans who have been pioneers in this space,” a recent article quotes Adams as saying. The article further notes that, once closed, the transaction will create a…

FridayOct 08, 2021 11:22 am

NetworkNewsBreaks – BBQ Holdings, Inc. (NASDAQ: BBQ) Featured in Research Note from Sidoti

Corporate Update BBQ Holdings (NASDAQ: BBQ) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “BBQ’s Acquisition of Tahoe Joe’s Adds Five Steakhouses and Compelling IP; We Continue To Forecast Higher Franchisee Royalties Starting 3Q:21; Maintain $19 Target, Moderate Risk Rating.” Click here to access the full report About BBQ Holdings, Inc. BBQ Holdings, Inc. is a national restaurant company engaged in the ownership and operation of casual and fast dining restaurants. As of September 20, 2021, BBQ Holdings had six brands with 296 locations in three countries including 84 Company…

ThursdayOct 07, 2021 2:32 pm

NetworkNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) Announces Entry into Strategic LOI

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent (“LOI”) for the formation of a commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI’s affiliate, Kingston Aluminum Technologies Inc. (“KAT”) will provide custom designed aluminum packaging for Sproutly’s products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly’s formulations made using ingredients produced by the proprietary APP cannabis processing technology. “This relationship will allow us to launch our beverages made…

ThursdayOct 07, 2021 2:12 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) Engages Clinipace in Pursuit of FDA Approval for Therapeutics

Clearmind Medicine (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced a strategic partnership. Clearmind has engaged Clinipace Incorporated, a full-service contract research organization (“CRO”), to advise the company in its pursuit of Food and Drug Administration (“FDA”) approval for its therapeutics. “Moving any drug through the FDA approval process requires deep expertise and meticulous attention to detail; this is particularly true for psychedelics,” said Adi Zuloff-Shani, PhD., CEO of Clearmind. “We chose Clinipace as our CRO as they have facilitated dozens of…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks